TARS logo

Tarsus Pharmaceuticals (TARS) Shareholders Equity

Annual Shareholders Equity

$196.99 M
+$4.09 M+2.12%

December 31, 2023


Summary


Performance

TARS Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTARSbalance sheetmetrics:

Quarterly Shareholders Equity

$237.48 M
-$14.76 M-5.85%

September 30, 2024


Summary


Performance

TARS Quarterly Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTARSbalance sheetmetrics:

Shareholders Equity Formula

Shareholders Equity = Total Assets − Total Liabilities

TARS Shareholders Equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+2.1%+20.6%
3 y3 years+18.7%+20.6%
5 y5 years+10000.0%+20.6%

TARS Shareholders Equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+18.1%-13.7%+60.8%
5 y5-yearat high+3380.4%-13.7%+1432.0%
alltimeall timeat high+3380.4%-13.7%+1432.0%

Tarsus Pharmaceuticals Shareholders Equity History

DateAnnualQuarterly
Sep 2024
-
$237.48 M(-5.9%)
Jun 2024
-
$252.25 M(-8.3%)
Mar 2024
-
$275.21 M(+39.7%)
Dec 2023
$196.99 M(+2.1%)
$196.99 M(-7.8%)
Sep 2023
-
$213.66 M(+44.6%)
Jun 2023
-
$147.73 M(-14.8%)
Mar 2023
-
$173.40 M(-10.1%)
Dec 2022
$192.90 M
$192.90 M(-4.8%)
Sep 2022
-
$202.63 M(-8.5%)
Jun 2022
-
$221.50 M(+48.5%)
DateAnnualQuarterly
Mar 2022
-
$149.20 M(-10.5%)
Dec 2021
$166.73 M(+0.5%)
$166.73 M(-6.9%)
Sep 2021
-
$179.14 M(-6.9%)
Jun 2021
-
$192.47 M(+5.0%)
Mar 2021
-
$183.23 M(+10.4%)
Dec 2020
$165.98 M(-2864.0%)
$165.98 M(-1031.0%)
Sep 2020
-
-$17.83 M(-134.0%)
Jun 2020
-
$52.37 M(-972.1%)
Dec 2019
-$6.00 M(+343.5%)
-$6.00 M
Dec 2018
-$1.35 M
-

FAQ

  • What is Tarsus Pharmaceuticals annual stockholders equity?
  • What is the all time high annual shareholders equity for Tarsus Pharmaceuticals?
  • What is Tarsus Pharmaceuticals annual shareholders equity year-on-year change?
  • What is Tarsus Pharmaceuticals quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Tarsus Pharmaceuticals?
  • What is Tarsus Pharmaceuticals quarterly shareholders equity year-on-year change?

What is Tarsus Pharmaceuticals annual stockholders equity?

The current annual shareholders equity of TARS is $196.99 M

What is the all time high annual shareholders equity for Tarsus Pharmaceuticals?

Tarsus Pharmaceuticals all-time high annual stockholders equity is $196.99 M

What is Tarsus Pharmaceuticals annual shareholders equity year-on-year change?

Over the past year, TARS annual stockholders equity has changed by +$4.09 M (+2.12%)

What is Tarsus Pharmaceuticals quarterly stockholders equity?

The current quarterly shareholders equity of TARS is $237.48 M

What is the all time high quarterly shareholders equity for Tarsus Pharmaceuticals?

Tarsus Pharmaceuticals all-time high quarterly stockholders equity is $275.21 M

What is Tarsus Pharmaceuticals quarterly shareholders equity year-on-year change?

Over the past year, TARS quarterly stockholders equity has changed by +$40.50 M (+20.56%)